Everhart Financial Group, Inc. Sellas Life Sciences Group, Inc. Transaction History
Everhart Financial Group, Inc.
- $1.05 Billion
- Q4 2025
A detailed history of Everhart Financial Group, Inc. transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Everhart Financial Group, Inc. holds 466,216 shares of SLS stock, worth $666,688. This represents 0.06% of its overall portfolio holdings.
Number of Shares
466,216
Previous 331,150
40.79%
Holding current value
$666,688
Previous $529,000
25.9%
% of portfolio
0.06%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding SLS
# of Institutions
101Shares Held
28.5MCall Options Held
3.85MPut Options Held
126K-
Vanguard Group Inc Valley Forge, PA6.84MShares$9.78 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX6.03MShares$8.63 Million1.59% of portfolio
-
Marshall Wace, LLP London, X02.36MShares$3.37 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.26MShares$3.24 Million0.0% of portfolio
-
State Street Corp Boston, MA1.36MShares$1.95 Million0.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $29.4M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...